Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Marcantoni

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Current Opinion in Nephrology and Hypertension|June 9, 1998
Angiotensin converting enzyme inhibitors in nondiabetic renal diseaseG Maschio, C Marcantoni
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|January 19, 2006
[The kidney in dysproteinemia]D Spanti, C Marcantoni, D Di Landro
Journal of Nephrology|August 6, 2000
Hypertension and progression of renal diseaseG Maschio, L Oldrizzi, C Marcantoni, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 31, 1998
Progression of renal failure in diabetic nephropathyC Marcantoni, V Ortalda, A Lupo, et al.
Annali Di Igiene : Medicina Preventiva E Di Comunita|July 21, 2011
[Health on front page: a content analysis of the main Italian newspapers in two months of 2009]C Marcantoni, M Bressanelli, G Orizio, et al.
Mineral and Electrolyte Metabolism|April 20, 1999
Management of hypertension in renal diseaseC Marcantoni, L Oldrizzi, C Rugiu, et al.
Journal of Nephrology|July 7, 2001
Resolution of renal disease: mission impossible?A Lupo, C Marcantoni, P Bernich, et al.
Journal of Preventive Medicine and Hygiene|July 4, 2015
Logistic regression of attitudes and coverage for influenza vaccination among Italian Public Health medical residentsV Di Gregori, G Franchino, C Marcantoni, et al.
Kidney International. Supplement|June 1, 2000
The role of systemic hypertension in the progression of nondiabetic renal diseaseC Marcantoni, T H Jafar, L Oldrizzi, et al.
Kidney International|April 25, 2001
Peroxisome proliferator-activated receptor-gamma agonist troglitazone protects against nondiabetic glomerulosclerosis in ratsL J Ma, C Marcantoni, M F Linton, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Current Opinion in Nephrology and Hypertension|June 9, 1998
Angiotensin converting enzyme inhibitors in nondiabetic renal diseaseG Maschio, C Marcantoni
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|January 19, 2006
[The kidney in dysproteinemia]D Spanti, C Marcantoni, D Di Landro
Journal of Nephrology|August 6, 2000
Hypertension and progression of renal diseaseG Maschio, L Oldrizzi, C Marcantoni, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 31, 1998
Progression of renal failure in diabetic nephropathyC Marcantoni, V Ortalda, A Lupo, et al.
Annali Di Igiene : Medicina Preventiva E Di Comunita|July 21, 2011
[Health on front page: a content analysis of the main Italian newspapers in two months of 2009]C Marcantoni, M Bressanelli, G Orizio, et al.
Mineral and Electrolyte Metabolism|April 20, 1999
Management of hypertension in renal diseaseC Marcantoni, L Oldrizzi, C Rugiu, et al.
Journal of Nephrology|July 7, 2001
Resolution of renal disease: mission impossible?A Lupo, C Marcantoni, P Bernich, et al.
Journal of Preventive Medicine and Hygiene|July 4, 2015
Logistic regression of attitudes and coverage for influenza vaccination among Italian Public Health medical residentsV Di Gregori, G Franchino, C Marcantoni, et al.
Kidney International. Supplement|June 1, 2000
The role of systemic hypertension in the progression of nondiabetic renal diseaseC Marcantoni, T H Jafar, L Oldrizzi, et al.
Kidney International|April 25, 2001
Peroxisome proliferator-activated receptor-gamma agonist troglitazone protects against nondiabetic glomerulosclerosis in ratsL J Ma, C Marcantoni, M F Linton, et al.
Pageof 2